Live Quote · NASDAQMYGNHealthcare· Medical - Diagnostics & Research

Myriad Genetics, Inc.

$5.46▼ 1.44%($-0.08)
MKT CAP $523.74MNEXT EARNINGS Feb 22, 2027
50%
Bullish
TickerSpark Score
60/100
▌ Mixed
73
Valuation
40
Profitability
15
Growth
72
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYGN research report →

Analyst Price Target
$5.42-0.7% vs. today

Range $3.6 – $8

Analyst RatingHold
8 Buy22 Hold7 Sell

Price Chart

-20.87% · this period
$7.91$5.38$2.86Nov 20May 26Nov 20
52-Week Range51% of range
Low
$2.74
Current
$5.46
High
$8.09